Pure Global
NCT06142422

Intermittent Theta Burst Stimulation of the Precuneus

Intermittent Theta Burst Stimulation of the Precuneus for the Treatment of Resistant Schizophrenia
GCS Ramsay Santé pour l'Enseignement et la Recherche·ClinicalTrials.gov·procedureNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Schizophrenia
Drug/Device/Intervention
stimulation device
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Location
Montpellier, France
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2024
End date
Jun 01, 2026
Enrollment
36 participants
Primary outcome

average of the Scale for assessment of negative symptoms/scale for assessment of positive symptoms scale scores

Summary

The purpose of the study is to compare the effectiveness of stimulation of the left precuneus
 by intermittent Theta Burst Stimulation to placebo stimulation on the severity of
 schizophrenia symptoms.

ICD-10 classifications
SchizophreniaSimple schizophreniaSchizophrenia, unspecifiedOther schizophreniaParanoid schizophrenia
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06142422
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06142422 through Pure Global AI's free database. This phase not specified trial is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche and is currently Not yet recruiting. The study focuses on Schizophrenia. Target enrollment is 36 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.